Prasco Launches Generic Testim Gel

Prasco announced that it has partnered with Auxilium to launch the authorized generic version of Auxilium's Testim (testosterone 1% gel) for the treatment of hypogonadism in adult males.

Testim, a Schedule III controlled substance, is indicated for testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).

RELATED: Androgens Treatment Chart

Endogenous androgens, including testosterone and dihydrotestosterone (DHT) are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include the growth and maturation of the prostate, seminal vesicles, penis, and scrotum; the development of male hair distribution, such as facial, pubic, chest, and axillary hair; laryngeal enlargement, vocal cord thickening, and alterations in body musculature and fat distribution.

For more information visit Prasco.com or Auxilium.com.

Loading links....